Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on LVMH MOET HENNESSY LOUIS VUI. We currently have 4 research reports from 1 professional analysts.
Frequency of research reports
Research reports on
LVMH MOET HENNESSY LOUIS VUI
LVMH MOET HENNESSY LOUIS VUI
The expansion bears fruit amidst a challenging context
11 Oct 16
The world luxury leader impressed once again, outperforming the market with 6% organic growth in Q3 16 to €9,138m. The performance was underpinned by positive momentum experienced by Perfumes & Cosmetics and Selective Retail growing by 10% and 8% respectively. Wines & Spirits slowed to an organic rise of 4% compared to 9% in H1. The Fashion segment accelerated by 5%, while sales were flat in the first half of the year. Watches & Jewellery products maintained the constant growth pace posted in Q2, edging up 2%. Over the first nine months, sales were up 4% (5% organic growth) to reach €26,326m. Perfumes & Cosmetics outperformed with 6% reported growth to €3,578m, i.e. 13.6% of total sales vs. 12.7% by the end of 2015. Both Wines and Selective Retail surged by 5% to reach €3,281m and €8,283m respectively. The spurt in Fashion & Leather goods in Q3 brought the nine-month performance to 1%, to €8,991m. This segment will be enhanced by the German high-end luggage maker Rimowa in 2017. Watches & Jewellery were up 3% to €2,486m. LVMH experienced favourable sales momentum across all regions, even in Asia which posted a significant upturn in Q3. The momentum remains unfavourable in France due to sliding tourist flows. The group has confirmed that its expansion strategy is going ahead in-depth via acquisitions and innovative products as well as in selective promising markets.
Comforting H1 performance
27 Jul 16
The pace of growth in early 2016 was maintained in Q2 amid a challenging global backdrop. Q2 sales grew at a modest 2%, bringing the H1 performance to 3% (€17,188m). Wines & spirits outperformed with a 7% surge to reach €2,056m, boosted by the strong momentum in cognac and spirits (+13% in volume and +10% in value). The core business retreated slightly by 1% to €5,933m despite the good progression of the main brands. All other segments experienced healthy growth (4-5%) with a marked outperformance in perfumes and cosmetics displaying an organic growth of 8%. Watches showed a strong resilience compared to the market, growing at 4% to reach €1,609m. The operating profit remained flat at €2,959m, pulled down by the deteriorating profitability of fashion & leather products, the main contributor to margins, and selective retail. The latter reported a 5% dwindling operating profit to €410m while the core business posted 2% decrease to €1,630m. Wines & spirits impressed with a 17% surge in operating profit to reach €565m. The group’s net profit benefited from lighter currency hedging costs and fewer financial expenses to reach €1,718m (+8%). Geographically, the US market experienced an impressive growth in both quarters bringing the H1 performance to 7% (organic). The market accounts for 26% of total sales. The Asian market (excl. Japan) reported a favourable momentum in Q2 increasing by 3% (-2% in Q1), although sales in Japan turned down (-5%) after a rise of 6% in Q1. Asia is still the main contributor to sales, accounting for 35%, of which 7% in Japan. Europe’s performance slowed down to 3% in Q2, i.e. growth of 5% in the first six months. Its contribution was reduced to 27% of which 10% in the home market. The strength of the financial structure was confirmed again with a drop in net debt of 12% yoy (€5,303m). Gearing was reduced to 16.9% vs. 19.8% a year earlier. The operating cash flow was consolidated from €1,494m in H1 15 to €1,632m in H1 16. The half year FCF gained €83m to reach €761m. An interim dividend of €1.4 will be paid in December 2016.
Healthy growth in Q1
13 Apr 16
LVMH experienced a rather shy quarter marked by the lacklustre demand for luxury fashion goods. Sales increased by 4%, of which organic growth of 3%, to reach €8,620m. Perfumes & Cosmetics outperformed with 9% lfl growth (€1,213m). Watches & Jewellery did better than the market and surged by 7% to €774m. The Wines & Spirits division grew by 6%, to €1,033m. The group’s performance was pulled down by the poor growth posted by the two largest contributors to sales as the fashion segment recorded flat sales at €2,965m and selective retail increased by 4% to €2,747m. Structural growth was nil for all segments. Geographically, LVMH experienced healthy growth (6-7%) in all regions except for Asia which retreated by 2% on an lfl basis. This latter accounted for 37% of Q1 sales compared to 26% in Europe (9% in France) and 25% in the USA.
FY15 results, beyond Chinese worries
04 Feb 16
LVMH outperformed all expectations posting 16% FY15 sales’ growth within a general economic slowdown, to €35.7bn. The organic growth was limited to 6% which is a strong figure in an industry expected to slowdown. The revenues benefited from the positive forex impact and the strengthening US$, as 32% of 2015 sales are invoiced in $. The underlying operating profit was up by 16%, worth €6.6bn, generating a net profit of €3,573m, i.e. 20% increase on a constant base. The selective retail impressed with 18% sales’ rise to €11.2bn boosted by an exceptional progress of Sephora. The core business, Fashion and leather goods grew by 14%. All segments posted significant profit growths pulled up by a 19% increase for Wines & Spirits and 10% for Fashion goods. The financial structure strengthened with ballooning FCF up by 30% and net debt decreasing by 12%. The proposed annual dividend is at €3.55, up by 11% compared to 2014.
The Slide Rule
12 Jan 17
What is The Slide Rule? The Slide Rule has been designed to dramatically simplify the identification of the best companies in the UK small/mid-cap sector by making a quantitative assessment of the relative potential of each company. At its core, The Slide Rule aims to identify those companies that create genuine shareholder value through strong returns on capital and solid growth, but also present a value opportunity with the potential tailwind of earnings momentum. Companies are assessed within a Quality, Value, Growth and Momentum (QVGM) framework.
23% profit growth in FY16 and a positive outlook in FY17 and FY18
18 Jan 17
FY16 results show a strong performance with 9.3% increase in revenue to £267.0m leading to a 23% increase in profitability as adj PBT increased to £40.2m (FY15 £32.8m). The 220bp improvement in gross margin underpinned the increase in profitability as legacy low margin projects continued to fall out of the mix. The 20.2% gross margin was ahead of the 19.5% forecast and in line with Group’s target of generating a through the cycle 20% margin. The forward sale announcements of five developments since the year end provide an increasing level of visibility on both FY17 and FY18, we estimate c. 70% of FY17 gross profit is currently derived from forward sold projects. The announcement on Duncan Road Stratford means the forward sold pipeline is already building into FY19. Current valuation does not reflect the forecast certainty with the shares trading on 9.0x FY17 earnings and yielding a prospective 5.1%.
N+1 Singer - Northern lights - Shining prospects for 2017
16 Jan 17
As the birthplace of Stephenson, Armstrong and Swan, the North East of England has a proud history of industrial and technological innovation. Despite local economic challenges, the region’s industrial heritage lives on through continuing success in high end engineering and technology. The recent takeovers of private equity backed SMD (subsea robotics) and Nomad Digital (wi-fi on the railways) are testament to this. The North East has also emerged as a leader in genetics and genomics with an enviable life sciences and healthcare infrastructure. Against this backdrop, we expect the region to continue to throw up attractive IPO candidates to build on the six new listings in the past three years. We expect 2017 to be far kinder to the existing portfolio of North East plcs than 2016 (a year to forget) with recent management changes one important theme for the new year. Our top picks are Hargreaves Services, Quantum Pharma and Zytronic (all N+1 Singer Corporate clients) and we are Buyers of Northgate and Grainger.
N+1 Singer - Morning Song 19-01-2017
19 Jan 17
Actual Experience (ACT LN) 2017 – a milestone year for revenue | Bagir Group (BAGR LN) Independent NED appointment to strengthen Board composition | Bioquell (BQE LN) Reassuring pre-close statement | Carador Income Fund (CIFU LN) Q4 dividend increased to 2.75c, 0.5c higher than forecast | FreeAgent (FREE LN) Contract with Royal Bank of Scotland | Halfords Group (HFD LN) Excellent Q3 update, special divi and confidence in FX mitigations | N Brown Group (BWNG LN) Robust peak trading with reversal of drag from older titles | NCC Group (NCC LN) Interims confirm underlying business sound | St Ives (SIV LN) Downgrade | Summit Therapeutics (SUMM LN) Dr David Roblin appointed Chief Operating Officer and R&D President | Wilmington Group (WIL LN) Acquisition – Further scaling of Healthcare
Another encouraging update reassures FY17 forecasts are intact
20 Jan 17
CCT has released another encouraging trading update, giving reassurance that FY17 consensus expectations remain firmly intact. We particularly note management commentary that the “cash position continues to strengthen considerably”, further adding to the £6.9m of net cash at FY16. This reminds us of one of CCT’s key investment attractions; the highly attractive financial model with low capital intensity provides the capacity for significant cash generation as profits continue to grow, in turn supporting a progressive dividend policy and the continuation of the multi-year share buyback programme. We maintain our BUY.
Small Cap Breakfast
19 Jan 17
SuperAwesome — The London based specialist in e-compliance is considering an IPO in its home town according to City A.M. Eco (Atlantic) Oil & Gas—TSX-V listed oil and gas exploration has announced its intention to float on AIM. Assets in Guyana and Namibia. Proposed £2m-£3m fundraise. Diversified Gas & Oil—According to LSE website first day of trading on AIM now expected for 30 January